Previous close | 170.19 |
Open | 171.14 |
Bid | 0.00 x 1100 |
Ask | 0.00 x 900 |
Day's range | 167.13 - 171.19 |
52-week range | 119.90 - 183.61 |
Volume | |
Avg. volume | 636,508 |
Market cap | 11.439B |
Beta (5Y monthly) | 1.26 |
PE ratio (TTM) | 14.43 |
EPS (TTM) | 11.77 |
Earnings date | 23 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | 0.80 (0.47%) |
Ex-dividend date | 29 Feb 2024 |
1y target est | 189.86 |
Universal Health Services (UHS) could produce exceptional returns because of its solid growth attributes.
Continued solid uptake of BD's (BDX) products is expected to have driven fiscal second-quarter revenues.
Encompass Health (EHC) increases its guidance for net operating revenues, which is in the range of $5.25-$5.325 million for 2024.